Wojciech P. Polkowski

Wojciech P. Polkowski

Auto-generated profile, based on publicly available information

Wojciech P. Polkowski

Medical University of Lublin

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
BBBjörn Ldm Brücher
Björn Ldm Brücher
GLGary Lyman
Gary Lyman
RHRichard van Hillegersberg
Richard van Hillegersberg
RPRaphael E. E Pollock
Raphael E. E Pollock
FLFlorian Lordick
Florian Lordick
IJIjaz S Jamall
Ijaz S Jamall
Since the “War on Cancer” was declared in 1971, the United States alone has expended some $300 billion on research, with a heavy focus on the role of genomics in anticancer therapy. Voluminous data have been collected and analyzed. However, in hindsight, any achievements made have not been realized in clinical practice in terms of overall survival or quality of life extended. This might be justified because cancer is not one disease but a conglomeration of multiple diseases, with widespread heterogeneity even within a single tumor type.

1 January 2016 in Family Medicine & Primary Care Review
Verified
Journal Article
Open access
RSRobert Sitarz
Robert Sitarz
MSMalgorzata Szlendak
Malgorzata Szlendak
MJMieczysław Jazienicki
Mieczysław Jazienicki
AKAndrzej Kurylcio
Andrzej Kurylcio
RWRyszard Wierzbicki
Ryszard Wierzbicki
WPWojciech P. Polkowski
Wojciech P. Polkowski
Background . Lipomas are the most common forms of benign soft tissue tumors. They occur as various-sized lumps that rarely transform into malignant tumors. They form as a result of a focal hypertrophy of adipose cells and are usually located subcutaneously. Generally, they are palpable through...

1 June 2006 in HPB
Verified
Journal Article
Closed access
PDF file
JMJerzy Mielko
Jerzy Mielko
WPWojciech P. Polkowski
Wojciech P. Polkowski
DSDanuta G. Skomra
Danuta G. Skomra
ASAndrzej J. Stanisławek
Andrzej J. Stanisławek
AKAndrzej M. Kurylcio
Andrzej M. Kurylcio
EKElżbieta M. Korobowicz
Elżbieta M. Korobowicz
The incidence of pancreatic carcinoma has increased during recent decades, and it is the fourth most common cause of cancer-related mortality [ 1 x [1] Eskelinen, M.J. and Haglund, U.H. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods. Eur J Surg. 1999; 165: 292–306 Crossref | PubMed | Scopus (41) | Google Scholar See all References , 2 x [2] Silverman, D.T., Schiffman, M., Everhart, J., Goldstein, A., Lillemoe, K.D., and Swanson, G.M. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999; 80: 1830–1837 Crossref | PubMed | Scopus (314) | Google Scholar See all References ]. Early systemic dissemination and local cancer progression are limitations of curative treatment [ 3 x [3] DiMagno, E.P., Reber, H.A., and Tempero, M.A. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology. 1999; 117: 1464–1484 Abstract | Full Text | Full Text PDF | PubMed | Scopus (320) | Google Scholar See all References ] [3] . Overall cumulative 5-year survival is extremely poor (0.4–1%), and after curative resection is only 5–15%[ 4 x [4] Bramhall, S.R., Allum, W.H., Jones, A.G., Allwood, A., Cummins, C., and Neoptolemos, J.P. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995; 82: 111–115 Crossref | PubMed | Scopus (449) | Google Scholar See all References , 5 x [5] Neoptolemos, J.P., Dunn, J.A., Stocken, D.D., Almond, J., Link, K., and Beger, H. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001; 358: 1576–1585 Abstract | Full Text | Full Text PDF | PubMed | Scopus (681) | Google Scholar See all References , 6 x [6] Yeo, C.J., Sohn, T.A., Cameron, J.L., Hruban, R.H., Lillemoe, K.D., and Pitt, H.A. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998; 227: 821–831 Crossref | PubMed | Scopus (331) | Google Scholar See all References , 7 x [7] Carr, J.A., Ajlouni, M., Wollner, I., Wong, D., and Velanovich, V. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival – a ten-year experience. Am Surg. 1999; 65: 1143–1149 PubMed | Google Scholar See all References ]. Pathological stage, histological differentiation, localization of the tumour and involved margins are known prognostic factors [ 8 x [8] Geer, R.J. and Brennan, M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993; 165: 68–72 Abstract | Full Text PDF | PubMed | Scopus (682) | Google Scholar See all References , 9 x [9] Fortner, J.G., Klimstra, D.S., Senie, R.T., and Maclean, B.J. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg. 1996; 223: 147–153 Crossref | PubMed | Scopus (213) | Google Scholar See all References , 10 x [10] Magistrelli, P., Antinori, A., Crucitti, A., La Greca, A., Masetti, R., and Coppola, R. Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol. 2000; 74: 36–40 Crossref | PubMed | Scopus (65) | Google Scholar See all References , 11 x [11] Lundin, J., Nordling, S., von Boguslawsky, K., Roberts, P.J., and Haglund, C. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Anticancer Res. 1995; 15: 2659–2668 PubMed | Google Scholar See all References , 12 x [12] Luttges, J., Schemm, S., Vogel, I., Hedderich, J., Kremer, B., and Kloppel, G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol. 2000; 191: 154–161 Crossref | PubMed | Scopus (103) | Google Scholar See all References , 13 x [13] Takahashi, T., Niino, N., Ishikura, H., Okushiba, S., Dohke, M., and Katoh, H. Predictive factors for long-term survival in patients with pancreatic carcinoma. Hepatogastroenterology. 1997; 44: 1463–1468 PubMed | Google Scholar See all References ].

1 January 2011 in Gastroenterology Review
Verified
Journal Article
Open access
MSMagdalena Skórzewska
Magdalena Skórzewska
WPWojciech P. Polkowski
Wojciech P. Polkowski
Pacjenci poddawani endoskopowej cholangiopankreatografii wstecznej (ECPW) powinni mieć wykonywane protezowanie dróg żółciowych, aby zapobiec zapaleniu dróg żółciowych. Najpoważniejszym jednak powikłaniem po ECPW jest zapalenie trzustki. Dane z piśmiennictwa na temat wpływu zapalenia...


6 November 2013
Verified
Book Chapter
Closed access
PDF file
KPKatharine Pigott
Katharine Pigott
FWFrederik Wenz
Frederik Wenz
MKMohammed Keshtgar
Mohammed Keshtgar
SESamy Eljamel
Samy Eljamel
WPWojciech P. Polkowski
Wojciech P. Polkowski
MEMichael Ehmann
Michael Ehmann